Presentation
DH11 - Leveraging Continuous Glucose Monitoring and Decision Dashboards in Diabetes Management: Scoping Review
DescriptionTopic:
The scoping review paper explores the multifaceted relationship between continuous glucose monitoring (CGM) and decision dashboards in the context of diabetes management. The lives of people with diabetes might be greatly improved by CGM technology, which offers real-time glucose level data, and decision dashboards, which help patients and healthcare professionals make educated decisions. This review leads with the objective of better understanding existing decision tools and dashboards and their uses to inform future designs for certain populations. This study intends to shed light on the uses, consequences, and efficacy of CGM and decision dashboards by synthesizing and analyzing the available literature, offering insightful information about their function in the healthcare environment.
Background:
Millions of people worldwide deal with diabetes every day, making it a major health concern. Effective glucose control is crucial to preventing complications and enhancing well-being. Traditional self-monitoring of blood glucose (SMBG) has limitations, such as discontinuous data and user error. By giving real-time glucose readings, continuous glucose monitoring (CGM) solves these problems. By analyzing this data and providing useful insights, decision dashboards raise the bar for CGM and eventually personalize diabetes therapy. While the potential benefits are clear, it is essential to evaluate the existing body of research to determine the state of knowledge and the key gaps in our understanding of CGM and decision dashboards. This review will provide a comprehensive overview of the current state of research and its implications for clinical practice and patient-centered care.
Overview of Presentation:
This scoping review will explore the pivotal role of continuous glucose monitoring (CGM) and decision dashboards in diabetes management, offering insights into their applications and implications. The presentation will cover the following key areas:
1. Introduction (Importance of the Message):
- The growing burden of diabetes and the need for innovative solutions.
- The role of CGM and decision dashboards in revolutionizing diabetes care.
- The importance of reviewing existing research to inform future developments.
2. Scope of the Review (Take Away Points):
- Defining the research question and objectives of the review.
- Clarifying the inclusion and exclusion criteria for the selected studies.
3. Applications and Implications (Take Away Points):
- How CGM technology empowers patients and healthcare providers.
- The role of decision dashboards in translating CGM data into actionable insights.
- Real-world applications in clinical practice, telemedicine, and home care.
4. Synthesis of Existing Literature (Take Away Points):
- Summarizing the key findings from selected studies.
- Categorizing research themes and trends in CGM and decision dashboard effectiveness.
- Identifying potential limitations or biases in literature.
5. Conclusion and Recommendations (Importance of the Message):
- Highlighting the practical implications of the review for clinical practice.
- Offering recommendations for future research and development in diabetes management.
This scoping review paper is a comprehensive exploration of CGM and decision dashboards in diabetes management, emphasizing that these technologies have the potential to transform care and improve outcomes. The takeaway points will revolve around the practical applications and implications of CGM and decision dashboards, physician vs patient-facing decision dashboards, extending outside of clinician offices, guiding future research and clinical practice in diabetes management.
The scoping review paper explores the multifaceted relationship between continuous glucose monitoring (CGM) and decision dashboards in the context of diabetes management. The lives of people with diabetes might be greatly improved by CGM technology, which offers real-time glucose level data, and decision dashboards, which help patients and healthcare professionals make educated decisions. This review leads with the objective of better understanding existing decision tools and dashboards and their uses to inform future designs for certain populations. This study intends to shed light on the uses, consequences, and efficacy of CGM and decision dashboards by synthesizing and analyzing the available literature, offering insightful information about their function in the healthcare environment.
Background:
Millions of people worldwide deal with diabetes every day, making it a major health concern. Effective glucose control is crucial to preventing complications and enhancing well-being. Traditional self-monitoring of blood glucose (SMBG) has limitations, such as discontinuous data and user error. By giving real-time glucose readings, continuous glucose monitoring (CGM) solves these problems. By analyzing this data and providing useful insights, decision dashboards raise the bar for CGM and eventually personalize diabetes therapy. While the potential benefits are clear, it is essential to evaluate the existing body of research to determine the state of knowledge and the key gaps in our understanding of CGM and decision dashboards. This review will provide a comprehensive overview of the current state of research and its implications for clinical practice and patient-centered care.
Overview of Presentation:
This scoping review will explore the pivotal role of continuous glucose monitoring (CGM) and decision dashboards in diabetes management, offering insights into their applications and implications. The presentation will cover the following key areas:
1. Introduction (Importance of the Message):
- The growing burden of diabetes and the need for innovative solutions.
- The role of CGM and decision dashboards in revolutionizing diabetes care.
- The importance of reviewing existing research to inform future developments.
2. Scope of the Review (Take Away Points):
- Defining the research question and objectives of the review.
- Clarifying the inclusion and exclusion criteria for the selected studies.
3. Applications and Implications (Take Away Points):
- How CGM technology empowers patients and healthcare providers.
- The role of decision dashboards in translating CGM data into actionable insights.
- Real-world applications in clinical practice, telemedicine, and home care.
4. Synthesis of Existing Literature (Take Away Points):
- Summarizing the key findings from selected studies.
- Categorizing research themes and trends in CGM and decision dashboard effectiveness.
- Identifying potential limitations or biases in literature.
5. Conclusion and Recommendations (Importance of the Message):
- Highlighting the practical implications of the review for clinical practice.
- Offering recommendations for future research and development in diabetes management.
This scoping review paper is a comprehensive exploration of CGM and decision dashboards in diabetes management, emphasizing that these technologies have the potential to transform care and improve outcomes. The takeaway points will revolve around the practical applications and implications of CGM and decision dashboards, physician vs patient-facing decision dashboards, extending outside of clinician offices, guiding future research and clinical practice in diabetes management.
Event Type
Poster Presentation
TimeTuesday, March 264:45pm - 6:15pm CDT
LocationSalon C
Digital Health
Simulation and Education
Hospital Environments
Medical and Drug Delivery Devices
Patient Safety Research and Initiatives